Global Oncolytic Virus Therapy Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Driven by the downstream end-users, the market of Oncolytic Virus Therapy witnessed a growth from XX.00 Million USD in 2014 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2019-2026 Oncolytic Virus Therapy market is offered. The research provides insights for the global Oncolytic Virus Therapy market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Oncolytic Virus Therapy industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Oncolytic Virus Therapy Market Segmentations:

    By Players:

    • PsiOxus Therapeutics

    • Lokon Pharma

    • Oncolytics Biotech

    • Genelux Corporation

    • Viralytics

    • Vyriad

    • Targovax

    • Cold Genesys

    • Amgen

    • SillaJen Biotherapeutics

    • TILT Biotherapeutics

    • Transgene SA

    • Sorrento Therapeutics

    • Oncolys BioPharma


    By Types:

    • HSV-based Oncolytic Viruses

    • Adenoviruses-based Oncolytic Viruses

    • Vaccinia Virus-based Oncolytic Viruses

    • Vesicular Stomatitis Virus-based Oncolytic Viruses

    • Newcastle Disease Virus-based Oncolytic Viruses


    By End-User:

    • Prostate Cancer

    • Melanoma

    • Ovarian Cancer

    • Breast Cancer

    • Others


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Oncolytic Virus Therapy Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Oncolytic Virus Therapy Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncolytic Virus Therapy Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Oncolytic Virus Therapy Market Share by Types

      • 1.3.2 Global Oncolytic Virus Therapy Market Size and Growth Rate of HSV-based Oncolytic Viruses from 2014 to 2026

      • 1.3.3 Global Oncolytic Virus Therapy Market Size and Growth Rate of Adenoviruses-based Oncolytic Viruses from 2014 to 2026

      • 1.3.4 Global Oncolytic Virus Therapy Market Size and Growth Rate of Vaccinia Virus-based Oncolytic Viruses from 2014 to 2026

      • 1.3.5 Global Oncolytic Virus Therapy Market Size and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses from 2014 to 2026

      • 1.3.6 Global Oncolytic Virus Therapy Market Size and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Oncolytic Virus Therapy Market Share by End-Users

      • 1.4.2 Global Oncolytic Virus Therapy Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

      • 1.4.3 Global Oncolytic Virus Therapy Market Size and Growth Rate of Melanoma from 2014 to 2026

      • 1.4.4 Global Oncolytic Virus Therapy Market Size and Growth Rate of Ovarian Cancer from 2014 to 2026

      • 1.4.5 Global Oncolytic Virus Therapy Market Size and Growth Rate of Breast Cancer from 2014 to 2026

      • 1.4.6 Global Oncolytic Virus Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 BelgiumOncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Oncolytic Virus Therapy Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncolytic Virus Therapy by Major Types

      • 3.4.1 Market Size and Growth Rate of HSV-based Oncolytic Viruses

      • 3.4.2 Market Size and Growth Rate of Adenoviruses-based Oncolytic Viruses

      • 3.4.3 Market Size and Growth Rate of Vaccinia Virus-based Oncolytic Viruses

      • 3.4.4 Market Size and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses

      • 3.4.5 Market Size and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses


    4 Segmentation of Oncolytic Virus Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncolytic Virus Therapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncolytic Virus Therapy for Prostate Cancer

      • 4.4.2 Market Size and Growth Rate of Oncolytic Virus Therapy for Melanoma

      • 4.4.3 Market Size and Growth Rate of Oncolytic Virus Therapy for Ovarian Cancer

      • 4.4.4 Market Size and Growth Rate of Oncolytic Virus Therapy for Breast Cancer

      • 4.4.5 Market Size and Growth Rate of Oncolytic Virus Therapy for Others


    5 Market Analysis by Major Regions

    • 5.1 Global Oncolytic Virus Therapy Production Analysis by Major Regions

    • 5.2 Global Oncolytic Virus Therapy Consumption Analysis by Major Regions

    • 5.3 Global Oncolytic Virus Therapy Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Oncolytic Virus Therapy Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Oncolytic Virus Therapy Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Oncolytic Virus Therapy Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Oncolytic Virus Therapy Production, Import, Consumption and Export Analysis


    6 Product Commodity of Oncolytic Virus Therapy Market in Major Countries

    • 6.1 Top 5 Export Countries in Oncolytic Virus Therapy market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Oncolytic Virus Therapy market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Oncolytic Virus Therapy market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Oncolytic Virus Therapy market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Oncolytic Virus Therapy market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Oncolytic Virus Therapy market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Oncolytic Virus Therapy Landscape Analysis

    • 7.1 North America Oncolytic Virus Therapy Landscape Analysis by Major Types

    • 7.2 North America Oncolytic Virus Therapy Landscape Analysis by Major End-Users

    • 7.3 North America Oncolytic Virus Therapy Landscape Analysis by Major Countries

      • 7.3.1 United States Oncolytic Virus Therapy Market Volume and Growth Rate

      • 7.3.2 Canada Oncolytic Virus Therapy Market Volume and Growth Rate

      • 7.3.3 Mexico Oncolytic Virus Therapy Market Volume and Growth Rate


    8 Europe Oncolytic Virus Therapy Landscape Analysis

    • 8.1 Europe Oncolytic Virus Therapy Landscape Analysis by Major Types

    • 8.2 Europe Oncolytic Virus Therapy Landscape Analysis by Major End-Users

    • 8.3 Europe Oncolytic Virus Therapy Landscape Analysis by Major Countries

      • 8.3.1 Germany Oncolytic Virus Therapy Market Volume and Growth Rate

      • 8.3.2 UK Oncolytic Virus Therapy Market Volume and Growth Rate

      • 8.3.3 France Oncolytic Virus Therapy Market Volume and Growth Rate

      • 8.3.4 Italy Oncolytic Virus Therapy Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Oncolytic Virus Therapy Market Volume and Growth Rate

      • 8.3.6 Spain Oncolytic Virus Therapy Market Volume and Growth Rate

      • 8.3.7 Belgium Oncolytic Virus Therapy Market Volume and Growth Rate

      • 8.3.8 Poland Oncolytic Virus Therapy Market Volume and Growth Rate

      • 8.3.9 Russia Oncolytic Virus Therapy Market Volume and Growth Rate

      • 8.3.10 Turkey Oncolytic Virus Therapy Market Volume and Growth Rate


    9 Asia Pacific Oncolytic Virus Therapy Landscape Analysis

    • 9.1 Asia Pacific Oncolytic Virus Therapy Landscape Analysis by Major Types

    • 9.2 Asia Pacific Oncolytic Virus Therapy Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Oncolytic Virus Therapy Landscape Analysis by Major Countries

      • 9.3.1 China Oncolytic Virus Therapy Market Volume and Growth Rate

      • 9.3.2 Japan Oncolytic Virus Therapy Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Oncolytic Virus Therapy Market Volume and Growth Rate

      • 9.3.4 India Oncolytic Virus Therapy Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Oncolytic Virus Therapy Market Volume and Growth Rate

      • 9.3.6 South Korea Oncolytic Virus Therapy Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Oncolytic Virus Therapy Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Oncolytic Virus Therapy Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Oncolytic Virus Therapy Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Oncolytic Virus Therapy Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Oncolytic Virus Therapy Market Volume and Growth Rate

      • 10.3.2 Brazil Oncolytic Virus Therapy Market Volume and Growth Rate

      • 10.3.3 Nigeria Oncolytic Virus Therapy Market Volume and Growth Rate

      • 10.3.4 South Africa Oncolytic Virus Therapy Market Volume and Growth Rate 

      • 10.3.5 Argentina Oncolytic Virus Therapy Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 PsiOxus Therapeutics

      • 11.1.1 PsiOxus Therapeutics Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Lokon Pharma

      • 11.2.1 Lokon Pharma Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Oncolytics Biotech

      • 11.3.1 Oncolytics Biotech Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Genelux Corporation

      • 11.4.1 Genelux Corporation Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Viralytics

      • 11.5.1 Viralytics Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Vyriad

      • 11.6.1 Vyriad Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Targovax

      • 11.7.1 Targovax Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Cold Genesys

      • 11.8.1 Cold Genesys Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Amgen

      • 11.9.1 Amgen Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 SillaJen Biotherapeutics

      • 11.10.1 SillaJen Biotherapeutics Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 TILT Biotherapeutics

      • 11.11.1 TILT Biotherapeutics Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Transgene SA

      • 11.12.1 Transgene SA Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Sorrento Therapeutics

      • 11.13.1 Sorrento Therapeutics Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Oncolys BioPharma

      • 11.14.1 Oncolys BioPharma Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 92 Figures and 161 Tables)

    • Figure Product Picture

    • Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of HSV-based Oncolytic Viruses from 2014 to 2026

    • Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Adenoviruses-based Oncolytic Viruses from 2014 to 2026

    • Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Vaccinia Virus-based Oncolytic Viruses from 2014 to 2026

    • Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses from 2014 to 2026

    • Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

    • Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Melanoma from 2014 to 2026

    • Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Ovarian Cancer from 2014 to 2026

    • Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Breast Cancer from 2014 to 2026

    • Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Oncolytic Virus Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oncolytic Virus Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oncolytic Virus Therapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncolytic Virus Therapy by Different Types from 2014 to 2026

    • Table Consumption Share of Oncolytic Virus Therapy by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of HSV-based Oncolytic Viruses

    • Figure Market Size and Growth Rate of Adenoviruses-based Oncolytic Viruses

    • Figure Market Size and Growth Rate of Vaccinia Virus-based Oncolytic Viruses

    • Figure Market Size and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses

    • Figure Market Size and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oncolytic Virus Therapy by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oncolytic Virus Therapy by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Prostate Cancer

    • Figure Market Size and Growth Rate of Melanoma

    • Figure Market Size and Growth Rate of Ovarian Cancer

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of Others

    • Table Global Oncolytic Virus Therapy Production by Major Regions

    • Table Global Oncolytic Virus Therapy Production Share by Major Regions

    • Figure Global Oncolytic Virus Therapy Production Share by Major Regions in 2014

    • Figure Global Oncolytic Virus Therapy Production Share by Major Regions in 2018

    • Figure Global Oncolytic Virus Therapy Production Share by Major Regions in 2026

    • Table Global Oncolytic Virus Therapy Consumption by Major Regions

    • Table Global Oncolytic Virus Therapy Consumption Share by Major Regions

    • Figure Global Oncolytic Virus Therapy Consumption Share by Major Regions in 2014

    • Figure Global Oncolytic Virus Therapy Consumption Share by Major Regions in 2018

    • Figure Global Oncolytic Virus Therapy Consumption Share by Major Regions in 2026

    • Table North America Oncolytic Virus Therapy Production, Import, Consumption and Export Analysis

    • Table Europe Oncolytic Virus Therapy Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Oncolytic Virus Therapy Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Oncolytic Virus Therapy Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Oncolytic Virus Therapy market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Oncolytic Virus Therapy market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Oncolytic Virus Therapy market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Oncolytic Virus Therapy market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Oncolytic Virus Therapy Consumption by Types from 2014 to 2026

    • Table North America Oncolytic Virus Therapy Consumption Share by Types from 2014 to 2026

    • Figure North America Oncolytic Virus Therapy Consumption Share by Types in 2014

    • Figure North America Oncolytic Virus Therapy Consumption Share by Types in 2018

    • Figure North America Oncolytic Virus Therapy Consumption Share by Types in 2026

    • Table North America Oncolytic Virus Therapy Consumption by End-Users from 2014 to 2026

    • Table North America Oncolytic Virus Therapy Consumption Share by End-Users from 2014 to 2026

    • Figure North America Oncolytic Virus Therapy Consumption Share by End-Users in 2014

    • Figure North America Oncolytic Virus Therapy Consumption Share by End-Users in 2018

    • Figure North America Oncolytic Virus Therapy Consumption Share by End-Users in 2026

    • Table North America Oncolytic Virus Therapy Consumption by Major Countries from 2014 to 2026

    • Table North America Oncolytic Virus Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Oncolytic Virus Therapy Consumption Share by Major Countries in 2014

    • Figure North America Oncolytic Virus Therapy Consumption Share by Major Countries in 2018

    • Figure North America Oncolytic Virus Therapy Consumption Share by Major Countries in 2026

    • Figure United States Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Oncolytic Virus Therapy Consumption by Types from 2014 to 2026

    • Table Europe Oncolytic Virus Therapy Consumption Share by Types from 2014 to 2026

    • Figure Europe Oncolytic Virus Therapy Consumption Share by Types in 2014

    • Figure Europe Oncolytic Virus Therapy Consumption Share by Types in 2018

    • Figure Europe Oncolytic Virus Therapy Consumption Share by Types in 2026

    • Table Europe Oncolytic Virus Therapy Consumption by End-Users from 2014 to 2026

    • Table Europe Oncolytic Virus Therapy Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Oncolytic Virus Therapy Consumption Share by End-Users in 2014

    • Figure Europe Oncolytic Virus Therapy Consumption Share by End-Users in 2018

    • Figure Europe Oncolytic Virus Therapy Consumption Share by End-Users in 2026

    • Table Europe Oncolytic Virus Therapy Consumption by Major Countries from 2014 to 2026

    • Table Europe Oncolytic Virus Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Oncolytic Virus Therapy Consumption Share by Major Countries in 2014

    • Figure Europe Oncolytic Virus Therapy Consumption Share by Major Countries in 2018

    • Figure Europe Oncolytic Virus Therapy Consumption Share by Major Countries in 2026

    • Figure Germany Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure France Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Oncolytic Virus Therapy Consumption by Types from 2014 to 2026

    • Table Asia Pacific Oncolytic Virus Therapy Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Oncolytic Virus Therapy Consumption Share by Types in 2014

    • Figure Asia Pacific Oncolytic Virus Therapy Consumption Share by Types in 2018

    • Figure Asia Pacific Oncolytic Virus Therapy Consumption Share by Types in 2026

    • Table Asia Pacific Oncolytic Virus Therapy Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Oncolytic Virus Therapy Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Oncolytic Virus Therapy Consumption Share by End-Users in 2014

    • Figure Asia Pacific Oncolytic Virus Therapy Consumption Share by End-Users in 2018

    • Figure Asia Pacific Oncolytic Virus Therapy Consumption Share by End-Users in 2026

    • Table Asia Pacific Oncolytic Virus Therapy Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Oncolytic Virus Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Oncolytic Virus Therapy Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Oncolytic Virus Therapy Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Oncolytic Virus Therapy Consumption Share by Major Countries in 2026

    • Figure China Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandOncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure India Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Oncolytic Virus Therapy Consumption Share by Major Countries in 2026

    • Figure GCC Countries Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Oncolytic Virus Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of PsiOxus Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PsiOxus Therapeutics

    • Figure Sales and Growth Rate Analysis of PsiOxus Therapeutics

    • Figure Revenue and Market Share Analysis of PsiOxus Therapeutics

    • Table Product and Service Introduction of PsiOxus Therapeutics

    • Table Company Profile and Development Status of Lokon Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lokon Pharma

    • Figure Sales and Growth Rate Analysis of Lokon Pharma

    • Figure Revenue and Market Share Analysis of Lokon Pharma

    • Table Product and Service Introduction of Lokon Pharma

    • Table Company Profile and Development Status of Oncolytics Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oncolytics Biotech

    • Figure Sales and Growth Rate Analysis of Oncolytics Biotech

    • Figure Revenue and Market Share Analysis of Oncolytics Biotech

    • Table Product and Service Introduction of Oncolytics Biotech

    • Table Company Profile and Development Status of Genelux Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genelux Corporation

    • Figure Sales and Growth Rate Analysis of Genelux Corporation

    • Figure Revenue and Market Share Analysis of Genelux Corporation

    • Table Product and Service Introduction of Genelux Corporation

    • Table Company Profile and Development Status of Viralytics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Viralytics

    • Figure Sales and Growth Rate Analysis of Viralytics

    • Figure Revenue and Market Share Analysis of Viralytics

    • Table Product and Service Introduction of Viralytics

    • Table Company Profile and Development Status of Vyriad

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vyriad

    • Figure Sales and Growth Rate Analysis of Vyriad

    • Figure Revenue and Market Share Analysis of Vyriad

    • Table Product and Service Introduction of Vyriad

    • Table Company Profile and Development Status of Targovax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Targovax

    • Figure Sales and Growth Rate Analysis of Targovax

    • Figure Revenue and Market Share Analysis of Targovax

    • Table Product and Service Introduction of Targovax

    • Table Company Profile and Development Status of Cold Genesys

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cold Genesys

    • Figure Sales and Growth Rate Analysis of Cold Genesys

    • Figure Revenue and Market Share Analysis of Cold Genesys

    • Table Product and Service Introduction of Cold Genesys

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of SillaJen Biotherapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SillaJen Biotherapeutics

    • Figure Sales and Growth Rate Analysis of SillaJen Biotherapeutics

    • Figure Revenue and Market Share Analysis of SillaJen Biotherapeutics

    • Table Product and Service Introduction of SillaJen Biotherapeutics

    • Table Company Profile and Development Status of TILT Biotherapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TILT Biotherapeutics

    • Figure Sales and Growth Rate Analysis of TILT Biotherapeutics

    • Figure Revenue and Market Share Analysis of TILT Biotherapeutics

    • Table Product and Service Introduction of TILT Biotherapeutics

    • Table Company Profile and Development Status of Transgene SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Transgene SA

    • Figure Sales and Growth Rate Analysis of Transgene SA

    • Figure Revenue and Market Share Analysis of Transgene SA

    • Table Product and Service Introduction of Transgene SA

    • Table Company Profile and Development Status of Sorrento Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics

    • Figure Sales and Growth Rate Analysis of Sorrento Therapeutics

    • Figure Revenue and Market Share Analysis of Sorrento Therapeutics

    • Table Product and Service Introduction of Sorrento Therapeutics

    • Table Company Profile and Development Status of Oncolys BioPharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oncolys BioPharma

    • Figure Sales and Growth Rate Analysis of Oncolys BioPharma

    • Figure Revenue and Market Share Analysis of Oncolys BioPharma

    • Table Product and Service Introduction of Oncolys BioPharma


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.